Table 3. P. aeruginosa MLVA9-UTRECHT typing results of four different patient populations.
group I | group IIa | group IIb | group II | group III | group IV | ||
CF | ICU -I | ICU-II | ICU total | Hospital acquired Non-CF/non-ICU | Community acquired Non-CF/non-ICU | Total | |
source | respiratory | respiratory | respiratory | respiratory | non-respiratory | non-respiratory | diverse |
# isolates (from # pat) | 100 (90) | 126 (97) | 79 (64) | 205 (161) | 39 (38) | 19 (19) | 363 (308) |
typeability | 88% | 93% | 100% | 95% | 87% | 89% | 91% |
# types | 72 | 82 | 63 | 142 | 33 | 17 | 252 |
Index of diversity | 0.984 | 0.981 | 0.991 | 0.991 | 0.989 | 0.988 | 0.995 |
CI | (0.971–0.996) | (0.97–0.992) | (0.983–0.999) | (0.987–0.996) | (0.977–1.0) | (0.969–1.0) | (0.993–0.997) |
Prevalent types (≥5%) | MT27(11%) MT11(5%) | MT44 (10%) MT68 (6%) | MT161 (8%) | NA | MT255 (5%) MT261 (5%) | MT276 (11%) MT212 (11%) | NA |
CF: cystic fibrosis patients, ICU: intensive care unit patients, MT: MLVA9-UTRECHT type,
#: number.